DCGI's Subject Expert Committee Grants 'in Principle' Approval to Bharat Biotech for ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'DCGI's Subject Expert Committee grants 'in principle' approval to Bharat Biotech for conduct of 'Phase III superiority study & Phase III booster dose study' for its intranasal COVID vaccine; asks it to submit protocols for approval'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)